Impact of Endoxifen-Guided Tamoxifen Dose Reductions on Endocrine Side Effects in Patients With Primary Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
ESMO Open 2023 Feb 06;8(1)100786, SM Buijs, EO Hoop, CL Braal, MM van Rosmalen, JC Drooger, QC van Rossum-Schornagel, MB Vastbinder, SLW Koolen, A Jager, RHJ MathijssenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.